EmpiRx Health Launches Infusion Therapy Management Solution to Cut Costs
EmpiRx Health has launched a new Infusion Therapy Management solution to help employers reduce costs and improve oversight of high-cost infusion treatments, announced in a press release.
The program shifts infusion therapies from being covered under medical benefits to pharmacy benefits, a move that increases pricing transparency and rebate opportunities. EmpiRx Health stated that this change can deliver more than 10% in savings for benefit plan sponsors while improving access to copay assistance.
The solution incorporates 24/7 care management and direct engagement with prescribing physicians to ensure appropriate drug selection, dosing, and cost. It also integrates the company’s Medication Optimization (MO) model, which uses AI-powered tools and pharmacist oversight to align treatment plans with clinical and financial goals.
According to the company, clients using the MO model have seen an average 15% reduction in drug spending within the first year, with continued optimization producing further savings over time.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, Sales & Marketing AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 20 IDC Names ZS a Leader in Life Sciences Evidence Services Sep 20 Brainomix Selected for UK Future Fifty Programme Sep 19 Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub Sep 19 Vetology Rebuilds 94 Veterinary Radiology AI Classifiers Sep 19 NAVER D2SF Backs ImpriMed in $10 Million Bridge RoundLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Medibyt Gets FDA Clearance for CPETWise Cardiopulmonary Test Software
HealthIQ Solutions and Eirion.ai Partner on Predictive AI for Remote Care
Empyrean Launches Halo AI Layer for Benefits Administration
Dimer Health Launches AiME for Post Discharge Care
UT Medical and TransformativeMed Build Agentic AI Discharge Planning Tool
Daily AI Brief: the AI news that matters, in your inbox.